Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach

• Published in: Patient preference and adherence Vol. 10; pp. 2217 - 2228
• Main Authors: Alten, Rieke, Krüger, Klaus, Rellecke, Julian, Schiffner-Rohe, Julia, Behmer, Olaf, Schiffhorst, Guido, Nolting, Hans-Dieter
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2016; Dove Medical Press
• Subjects: Analysis; Antiarthritic agents; Antirheumatic agents; Arthritis; Best-Worst Scaling; Discrete Choice Experiment; Disease-Modifying Anti-Rheumatic Drugs; Diseases; Drug therapy; Medical research; Methotrexate; Original Research; Patient compliance; Patient Preferences; Regression analysis; Rheumatoid Arthritis; Rheumatoid factor; Time; Germany; best–worst scaling; discrete-choice experiment; rheumatoid arthritis; disease-modifying antirheumatic drugs; patient preferences

Biological disease-modifying antirheumatic drugs (bDMARDs) used in second-line treatment of rheumatoid arthritis (RA) are administered parenterally. However, so-called targeted synthetic DMARDs (tsDMARDs) - developed more recently - offer alternative (ie, oral) administration forms in second-line tr...